The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Clinical trial NCT06021977 · UNKNOWN
Trial details
- NCT number
- NCT06021977
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-09-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.